{"summary": "mr Cerami was one of the youngest full professors at Rockefeller and Cornell universities. he had just interviewed for the MD/PhD biomedical scientist training program. he was headed back to new Haven, Connecticut, where he was a senior major in molecular biophysics and biochemistry. a 1962 paper published in experimental parasitology by a rockefeller parasitologist. the paper had the title \u201cOn Endemic Hookworm, Where Do We Stand Today\u201d. despite the fact that hookworm infection was generally acknowledged as a leading cause of global anemia, I can remember going to index Medicus. working on hookworm was a great fit with the Rockefeller Foundation\u2019s new Great Neglected Diseases of Mankind program, launched in 1977 by Dr. Kenneth Warren (1929\u20131996) (2,4). like Tony, Ken was also a scientific and medical visionary, who had the idea to fund world-class scientific units in the united states. HUMAN HOOKWORM VACCINE trained in pediatrics and pediatric infectious diseases at Harvard and Yale before becoming a Principal Investigator at Yale. in 2000, we received large-scale support from the Bill and Melinda Gates Foundation to develop these molecules as recombinant vaccines for clinical testing. she was fortunate enough to learn from major general Dr. Philip K Russell (now retired) the first human hookworm vaccine is in clinical trials in brazil. the first human hookworm vaccine is in clinical trials in brazil. the first human hookworm vaccine is in clinical trials in brazil. a multivalent vaccine could target all three soil-transmitted helminths and schistosomiasis. a new antiviral vaccine for severe acute respiratory syndrome (SARS) could also lead to a vaccine for Middle East respiratory syndrome (MERS) ascariasis 819 million Asia, sub-Saharan Africa, Latin America Preventive (8) Hookworm infection 440 million Asia, sub-Saharan Africa, Latin America Preventive (7) Schistosomiasis 252 million Sub-Saharan Africa, Brazil Preventive (9) Cutaenous leishmaniasis 10 million Mesoamerica Preventive (12) Chagas disease 7.5 million Mesoamerica Therapeutic (11) SARS/MERS 1,000 Asia/Mi we led global efforts to get 13\u201314 of these conditions recognized as \u201cneglected tropical diseases\u201d (NTDs), of which at least seven NTDs could be targeted almost simultaneously with low-cost generic drugs or ones donated by multinational pharmaceutical companies (17\u201319). we also established an alliance of partners\u2014the Global Network for NTDs\u2014to advocate for people who require access to essential NTD medicines. a NATIONAL SCHOOL OF TROPICAL MEDICINE IN HOUSTON. the concept of NTDs disproportionately affects the poor living in wealthy countries. in 2011, we relocated the Sabin Vaccine Institute PDP to Houston. both the Sabin Vaccine Institute and Texas Children\u2019s Hospital Center for Vaccine Development and Baylor College of Medicine will face a number of exciting challenges. one of them is the prospect of disease elimination, with only smallpox eradicated. cy can enhance U.S. scientific or foreign policy outreach. cy can lead to the development and global access of new antipoverty vaccines, drugs and diagnostics."}